Indaptus Therapeutics, Inc.

( )
NTEC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. 1.40%53.600.0%$627.30m
CTLTCatalent, Inc. -0.08%135.982.0%$167.28m
VRXValeant Pharmaceuticals International, Inc. 0.00%28.2114.1%$165.99m
PRGOPerrigo Co. Plc 0.68%43.036.9%$139.81m
ICLRICON plc 0.00%269.962.8%$115.50m
HZNPHorizon Therapeutics Plc 0.00%109.765.5%$105.41m
JAZZJazz Pharmaceuticals Plc 0.00%129.102.1%$95.77m
INDPIndaptus Therapeutics, Inc. 0.36%8.300.0%$93.33m
ARGXargenx SE -1.70%311.000.0%$67.19m
BHCBausch Health Cos., Inc. 0.00%28.210.0%$57.35m
AXSMAxsome Therapeutics, Inc. -0.58%31.031.8%$53.74m
UTHRUnited Therapeutics Corp. 0.00%198.8314.0%$49.03m
ENDPEndo International Plc -0.36%2.758.5%$48.70m
SAGESAGE Therapeutics, Inc. 0.00%45.237.6%$21.01m
IRWDIronwood Pharmaceuticals, Inc. 0.00%12.679.5%$20.95m

Company Profile

Indaptus Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on research and development and clinical trials. The company develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill. The Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing efficient gastric retention. The company is headquartered in Jerusalem, Israel.